Table 4.
Intralaboratory and interlaboratory reproducibility of OncoPredict HPV® SCR
| First analysis in Unimib | ||||
|---|---|---|---|---|
| Intralaboratory analysis a | ||||
| Second analysis in Unimib | Positive | Negative | Total | |
| Positive | 136 | 1 | 137 | |
| Negative | 5 | 381 | 376 | |
| Total | 141 | 382 | 523 | |
| Interlaboratory analysis b | ||||
| Second analysis in PTP | Positive | Negative | Total | |
| Positive | 132 | 1 | 133 | |
| Negative | 9 | 381 | 390 | |
| Total | 141 | 832 | 523 | |
Abbreviation: HPV, human papillomavirus.
a
Overall HPV test agreement: 98.9 (95% CI 97.5%–99.6%); Kappa: 0.971 (95% CI 0.947–0.994)—indicating an excellent intralaboratory agreement.
b
Overall HPV test agreement: 98.1 (95% CI 96.5%–99.1%); Kappa: 0.951 (95% CI 0.920–0.981)—indicating an excellent inter‐laboratory agreement.